Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Other Accumulated Expenses (2016 - 2025)

Lifevantage's Other Accumulated Expenses history spans 15 years, with the latest figure at $6.7 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 40.61% year-over-year to $6.7 million; the TTM value through Dec 2025 reached $6.7 million, down 40.61%, while the annual FY2025 figure was $13.5 million, 71.62% up from the prior year.
  • Other Accumulated Expenses reached $6.7 million in Q4 2025 per LFVN's latest filing, up from $6.6 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $14.5 million in Q1 2025 to a low of $5.1 million in Q3 2022.
  • Average Other Accumulated Expenses over 5 years is $8.0 million, with a median of $7.3 million recorded in 2021.
  • The largest YoY upside for Other Accumulated Expenses was 107.45% in 2025 against a maximum downside of 40.61% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $6.7 million in 2021, then decreased by 4.43% to $6.4 million in 2022, then increased by 17.27% to $7.5 million in 2023, then skyrocketed by 50.47% to $11.3 million in 2024, then plummeted by 40.61% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for LFVN's Other Accumulated Expenses are $6.7 million (Q4 2025), $6.6 million (Q3 2025), and $13.5 million (Q2 2025).